Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
St. Jude Children's Research Hospital
Massachusetts General Hospital
Dana-Farber Cancer Institute
Roswell Park Cancer Institute
University of Florida
MedSIR
Royal Marsden NHS Foundation Trust
Dana-Farber Cancer Institute
University of Florida
Essen Biotech
Royal Marsden NHS Foundation Trust
Centre Leon Berard
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Iowa
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Institut Bergonié
Swiss Cancer Institute
National Taiwan University Hospital
Hadassah Medical Organization
Massachusetts General Hospital
Essen Biotech
University of California, Irvine
Cancer Research UK
Esperas Pharma Inc.
University of Washington
Columbia University
Sarcoma Oncology Research Center, LLC
Sarcoma Oncology Research Center, LLC
Sarcoma Oncology Research Center, LLC
Bambino Gesù Hospital and Research Institute
University Hospital, Antwerp
University of Maryland, Baltimore
Grupo Espanol de Investigacion en Sarcomas
Fred Hutchinson Cancer Center
Centre Leon Berard
University of Iowa
Second Affiliated Hospital of Guangzhou Medical University
University of Iowa
City of Hope Medical Center
Grupo Espanol de Investigacion en Sarcomas
Grupo Espanol de Investigacion en Sarcomas
Institut Bergonié
Ludwig Institute for Cancer Research
Swiss Cancer Institute
University of Pittsburgh
Maria Sklodowska-Curie National Research Institute of Oncology
Yonsei University
Institut Bergonié